BIO

NYSE Bio-Rad Laboratories, Inc. Class A

Oct 25, 2026 · 7:56 PM ET EOD Market Closed

$369.95 ↑ +0.00 (+0.00%) Trading Up from the previous close of $369.95, $1.36 below the day’s high of $371.31

YTD change: +22.10%
vs 20-day SMA: +1.02%
vs 200-day SMA: +18.67%

Price ranges

Previous day

$352.46 $371.31

open $361.39 close $369.95

+$8.56 (+2.37%)

Today

$352.46 $371.31

$369.95

Past week

$347.29 $369.37

from $364.82 now $369.95

+$5.13 (+1.41%)

Past month

$347.29 $390.00

from $387.54 now $369.95

-$17.59 (-4.54%)

This year

$236.73 $396.23

from $302.99 now $369.95

+$66.96 (+22.10%)

Price & Performance

+82.66 (+28.77%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 55.6% away from all-time highs of $832.70
BIO is up 22% since the beginning of the year
BIO is up 9% over the past 12 months
BIO is down 5% over the past 1 month
7% of all BIO investors are betting against BIO
Number of investors short BIO has gone up 5% versus last month

BIO reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +10.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $2.62

Earnings momentum -17.8% Quarterly EPS growth

Quarterly change -17.8%

Valuation

P/E ratio 45.12

Enterprise value $9.5B

Beta 1.19

Balance sheet & scale

Income$222.4K

Revenue$2.6B

Cash$1.6B

Debt$1.4M

Income / Debt 0.16×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Computer and Electronic Product Manufacturing

Market cap $8.0B

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Competitor comparison

Ticker	Company	Price	Change
A	Agilent Technologies, Inc.	$173.07	-0.47%
WAT	Waters Corporation	$453.67	-0.42%
ILMN	Illumina, Inc.	$269.42	+0.01%
MTD	Mettler-Toledo International Inc.	$1,670.29	-0.85%
RVTY	Revvity, Inc.	$158.77	+0.90%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.